Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
Recruiting · NCT00748254 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Michigan
View the official record on ClinicalTrials.gov →Interventions studied
Laser Based Photoacoustic Tomography, MRI, Ultrasound
What this trial is about
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Men and women 18 years of age or older can participate in this study.
- Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study.
- Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis.
Exclusion criteria
- Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- Pregnant patients.
- Patients who is claustrophobic.
- Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.
- Patients with shock hypotension or unstable low blood pressure.
- Patients with Rhabdomyolysis.
- Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).
Where it is running
1 location listed across 1 US state.
- Universtity of Michigan Health System - Ann Arbor, Michigan, United States